Radical new combo: cut out tumor, then hit it with drugs
NCT ID NCT07177105
Summary
This study is testing if surgically removing the main lung tumor before starting a combination of immunotherapy and chemotherapy leads to better outcomes for people with advanced lung cancer. About 118 patients will be randomly assigned to either have surgery first or just receive the drug treatment. Researchers will compare how long patients live without their cancer getting worse, overall survival, and quality of life to see if adding surgery provides a significant benefit.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.